Evidence map›Paper›PMID 26704433›Full record

ArticleBMC cancer2015

A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion.

László Mangel, Krisztina Bíró, István Battyáni, Péter Göcze, Tamás Tornóczky, Endre Kálmán

Abstract readCase Reports
In one paragraph

Article in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

László MangelInstitute of Oncotherapy, University of Pécs, H-7624, Édesanyák útja 17, Pécs, Hungary. mangellaszlo@gmail.com.
Krisztina BíróDepartment of Chemotherapy, National Institute of Oncology, Budapest, Hungary. szbirokriszta@gmail.com.
István BattyániDepartment of Radiology, University of Pécs, Pécs, Hungary. batyo@chello.hu.
Péter GöczeClinic of Obstetrics and Gynecology, University of Pécs, Pécs, Hungary. peter.gocze@aok.pte.hu.
Tamás TornóczkyInstitute of Pathology, University of Pécs, Pécs, Hungary. ttamas64@hotmail.com.
Endre KálmánInstitute of Pathology, University of Pécs, Pécs, Hungary. ke6100@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTreatment possibilities of metastatic renal cell carcinoma (mRCC) have recently changed dramatically prolonging the overall survival of the patients. This kind of development brings new challenges for the care of mRCC. CASE PRESENTATION: A 22 year-old female patient with translocation type mRCC, who previously had been treated for nearly 5 years, became pregnant during the treatment break period. Follow-up examinations revealed a dramatic clinical and radiological progression of mRCC in a few weeks therefore the pregnancy was terminated. A few days after surgical abortion, CT examination showed a significant spontaneous regression of the pulmonary metastases, and the volume of the largest manifestation decreased from ca. 30 to 3.5 cm(3) in a week. To understand the possible mechanism of this spectacular regression, estrogen, progesterone and luteinizing hormone receptors (ER, PGR and LHR, respectively) immuno-histochemistry assays were performed on the original surgery samples. Immuno-histochemistry showed negative ER, PGR and positive LHR status suggesting the possible angiogenic effect of human chorionic gonadotropin hormone (hCG) in the background.

conclusionWe hypothesize that pregnancy may play a causal role in the progression of mRCC via the excess amount of hCG, however, more data are necessary to validate the present notions and the predictive role of LHR overexpression.

Indexed as

Abortion, TherapeuticNeoplasm Regression, SpontaneousCarcinoma, Renal CellChorionic GonadotropinFemaleHumansKidney NeoplasmsNeovascularization, PathologicPregnancyPregnancy Complications, NeoplasticYoung AdultChorionic Gonadotropin

Identifiers

PMID26704433
PMCPMC4691015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.